TGFB1 and neoplasm: While reducing the number of Tregs within the primary tumor and reducing the ability of the remaining Tregs to promote EMT, LFPRLR SMO treatment did not affect the ability of Tregs to produce the classical immune suppressive cytokines, IL-10 and TGF-β1.